Santosh Sankar

GlaxoSmithKline Makes Generics Deal to Penetrate Emerging Markets

A great move by GSK to enter the generic market. Once you can offer both patented products and generics, you can stand up to competition from the pure generic companies who are eating away at potential profits from your patented prescriptions.